Fiscal Wizard · Single-issue tearsheet

CRL / May 12, 2026 Run #8

CRL

Charles River Laboratories International, Inc.

Diagnostics & Research

Composite verdict

F 10.0 / 100

Weak across fundamentals and technicals.

Industry rank 13th of 14 in Diagnostics & Research

industry=Diagnostics & Research

Fundamentals Weak

20.0 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 34 metrics shown.

Strongest
Weakest
Free Cash Flow Yield 77
Greenblatt EY 0
EV/Sales 75
Return on Capital Employed 0
P/B 75
Return on Assets 0

Technicals Weak

0.0 / 100

Bearish setup leads (MA Rejection, Multi Top/Bottom, Relative Strength vs SPY); bulls voided by gates. · 26 signals shown.

Strongest
Weakest
Head and Shoulders 50
MA Rejection 0
Connors RSI(2) 42
Relative Strength vs SPY 7
Pin Bar 42
Wedge Pattern 9

Risk Gates

6 blocking 4 caution

6 gates blocking, 17 signals voided.

  • Interest Coverage voids RSI Divergence, Stochastic Cross +13
  • Net Debt / EBITDA voids RSI Divergence, Stochastic Cross +13
  • Piotroski F-Score voids RSI Divergence, Stochastic Cross +13
  • ADX Trend Weakness voids Trendline Break, Donchian Breakout +3

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for CRL.